Conceptio › Archive › HAL (France)
HAL (France)open access

Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study

Amit Pandya et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 126877
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.